These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32163115)

  • 1. The Glycine Receptor Allosteric Ligands Library (GRALL).
    Cerdan AH; Sisquellas M; Pereira G; Barreto Gomes DE; Changeux JP; Cecchini M
    Bioinformatics; 2020 Jun; 36(11):3379-3384. PubMed ID: 32163115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pharmacology of the glycine receptor chloride channel.
    Webb TI; Lynch JW
    Curr Pharm Des; 2007; 13(23):2350-67. PubMed ID: 17692006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of N-acyl amino acids that are positive allosteric modulators of glycine receptors.
    Gallagher CI; Sheipouri D; Shimmon S; Rawling T; Vandenberg RJ
    Biochem Pharmacol; 2020 Oct; 180():114117. PubMed ID: 32579961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular sites for the positive allosteric modulation of glycine receptors by endocannabinoids.
    Yévenes GE; Zeilhofer HU
    PLoS One; 2011; 6(8):e23886. PubMed ID: 21901142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual cooperative allosteric modulation of binding to ionotropic glycine receptors.
    Maksay G; Bíró T
    Neuropharmacology; 2002 Dec; 43(7):1087-98. PubMed ID: 12504915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of a Structurally Important Extracellular Element in the Glycine Receptor Leads to Decreased Synaptic Integration and Signaling Resulting in Severe Startle Disease.
    Schaefer N; Berger A; van Brederode J; Zheng F; Zhang Y; Leacock S; Littau L; Jablonka S; Malhotra S; Topf M; Winter F; Davydova D; Lynch JW; Paige CJ; Alzheimer C; Harvey RJ; Villmann C
    J Neurosci; 2017 Aug; 37(33):7948-7961. PubMed ID: 28724750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations within the agonist-binding site convert the homomeric alpha1 glycine receptor into a Zn2+-activated chloride channel.
    Grudzinska J; Schumann T; Schemm R; Betz H; Laube B
    Channels (Austin); 2008; 2(1):13-8. PubMed ID: 18690053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel specific allosteric modulators of the glycine receptor using phage display.
    Tipps ME; Lawshe JE; Ellington AD; Mihic SJ
    J Biol Chem; 2010 Jul; 285(30):22840-5. PubMed ID: 20501662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine Receptor Drug Discovery.
    Lynch JW; Zhang Y; Talwar S; Estrada-Mondragon A
    Adv Pharmacol; 2017; 79():225-253. PubMed ID: 28528670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the neurosteroid binding sites on glycine receptors.
    Alvarez LD; Pecci A
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105388. PubMed ID: 31176751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular requirements for ethanol differential allosteric modulation of glycine receptors based on selective Gbetagamma modulation.
    Yevenes GE; Moraga-Cid G; Avila A; Guzmán L; Figueroa M; Peoples RW; Aguayo LG
    J Biol Chem; 2010 Sep; 285(39):30203-13. PubMed ID: 20647311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive Allosteric Modulators of Glycine Receptors and Their Potential Use in Pain Therapies.
    Gallagher CI; Ha DA; Harvey RJ; Vandenberg RJ
    Pharmacol Rev; 2022 Oct; 74(4):933-961. PubMed ID: 36779343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of glycine receptor function: a novel approach for therapeutic intervention at inhibitory synapses?
    Laube B; Maksay G; Schemm R; Betz H
    Trends Pharmacol Sci; 2002 Nov; 23(11):519-27. PubMed ID: 12413807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The startle disease mutation α1S270T predicts shortening of glycinergic synaptic currents.
    Wu Z; Lape R; Jopp-Saile L; O'Callaghan BJ; Greiner T; Sivilotti LG
    J Physiol; 2020 Aug; 598(16):3417-3438. PubMed ID: 32445491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive allosteric modulators differentially affect full versus partial agonist activation of the glycine receptor.
    Kirson D; Todorovic J; Mihic SJ
    J Pharmacol Exp Ther; 2012 Jul; 342(1):61-70. PubMed ID: 22473615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric ligands and their binding sites define γ-aminobutyric acid (GABA) type A receptor subtypes.
    Olsen RW
    Adv Pharmacol; 2015; 73():167-202. PubMed ID: 25637441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterisation of the human alpha1 glycine receptor in a fluorescence-based membrane potential assay.
    Jensen AA; Kristiansen U
    Biochem Pharmacol; 2004 May; 67(9):1789-99. PubMed ID: 15081878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a mutation in the TM2-TM3 linker region of the glycine receptor alpha1 subunit on gating and allosteric modulation.
    Dupre ML; Broyles JM; Mihic SJ
    Brain Res; 2007 Jun; 1152():1-9. PubMed ID: 17434460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding-site mutations in the alpha1 subunit of the inhibitory glycine receptor convert the inhibitory metal ion Cu2+ into a positive modulator.
    Schumann T; Grudzinska J; Kuzmin D; Betz H; Laube B
    Neuropharmacology; 2009 Jan; 56(1):310-7. PubMed ID: 18793654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bidirectional allosteric modulation of strychnine-sensitive glycine receptors by tropeines and 5-HT3 serotonin receptor ligands.
    Maksay G
    Neuropharmacology; 1998 Dec; 37(12):1633-41. PubMed ID: 9886686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.